Physician profile
Sonia Jain
NPI 1134386188
$535.20
in general payments reported to CMS, 2019-2025
13 companies · $70.00 in 2025
The $70.00 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.03 · 2020: $103 · 2021: $39.35 · 2022: $101 · 2023: $72.24 · 2024: $92.13 · 2025: $70.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $135.26 | 2020-2022 | |
| Pfizer INC. | $95.79 | 2024-2025 | |
| Sanofi Pasteur INC. | $57.92 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $41.06 | 2023 | Jornay Pm |
| Seqirus USA INC | $40.59 | 2022-2023 | Flucelvax Quadrivalent |
| Merck Sharp & Dohme LLC | $34.12 | 2019-2022 | |
| Ars Pharmaceuticals Operations, INC. | $32.84 | 2025 | Neffy |
| Phadia US INC. | $18.90 | 2024 | Immunocap |
| Aytu Biopharma, INC. | $17.96 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $16.19 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.15 | 2019 | |
| Glaxosmithkline, LLC. | $14.82 | 2023 | Bexsero |
| Sanofi-Aventis U.S. LLC | $14.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.